Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP1LC3B | Q9GZQ8 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HTR2C | P28335 | 2/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 5/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.46 |
| ▸ | DRD2 | P14416 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30368251 | 1.00 | MAP1LC3B (0.57) | MAP1LC3BTP53RECQLHTR2CMAPT | |
| SCHEMBL11350470 | 0.91 | MAP1LC3B (0.50) | MAP1LC3BTP53RECQLHTR2CMAPT | |
| SCHEMBL30384404 | 0.86 | MAP1LC3B (0.54) | MAP1LC3BHTR2CMAPTMEN1KMT2A | |
| SCHEMBL14950769 | 0.85 | TSHR (0.49) | MAP1LC3BTP53RECQLMAPTGAA | |
| SCHEMBL29008634 | 0.85 | MAP1LC3B (0.45) | MAP1LC3BTP53RECQLHTR2CMAPT | |
| SCHEMBL12635245 | 0.83 | ADRA1A (0.55) | MAP1LC3BHTR2CMEN1KMT2AUSP2 | |
| SCHEMBL30129583 | 0.83 | ADRA1A (0.55) | MAP1LC3BHTR2CMEN1KMT2AUSP2 | |
| SCHEMBL12635239 | 0.83 | ADRA1A (0.55) | MAP1LC3BHTR2CMEN1KMT2AUSP2 | |
| SCHEMBL12667873 | 0.83 | ADRA1A (0.55) | MAP1LC3BHTR2CMEN1KMT2AUSP2 | |
| SCHEMBL824116 | 0.81 | HTR2C (0.53) | MAP1LC3BHTR2CMEN1KMT2AUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113563509-B | Composition for preparing fracturing thickening agent, fracturing thickening agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-12-07 | — | — | CN | claimed |
| CN-113563509-A | Composition for preparing fracturing thickening agent, fracturing thickening agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-10-29 | — | — | CN | claimed |
| EP-4727923-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | University of Georgia Research Foundation, Inc. (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260102387-A1 | IMMUNOSUPPRESSIVE COMPOUNDS | UNIV BASEL (CH) | 2026-04-16 | — | — | US | disclosed |
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIV GEORGIA (US) | 2026-04-09 | — | — | US | disclosed |
| US-12209172-B2 | Curable compositions and methods of using the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2025-01-28 | — | — | US | disclosed |
| WO-2024258904-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2024-12-19 | — | — | WO | disclosed |
| WO-2024069007-A2 | IMMUNOSUPPRESSIVE COMPOUNDS | UNIVERSITÄT BASEL (CH) | 2024-04-04 | — | — | WO | disclosed |
| US-20230133261-A1 | CURABLE COMPOSITIONS AND METHODS OF USING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2023-05-04 | — | — | US | disclosed |
| CN-115380053-A | Curable compositions and methods of using curable compositions | 3M创新有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-113563509-B | Composition for preparing fracturing thickening agent, fracturing thickening agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2021-12-07 | — | — | CN | disclosed |
| EP-2249818-A1 | HEDGEHOG PATHWAY ANTAGONISTS AND METHODS OF USE | Stanford University (US) | 2010-11-17 | — | — | EP | disclosed |
| EP-2144889-A2 | QUINAZOLIN-OXIME DERIVATIVES AS HSP90 INHIBITORS | DAC S.r.l. (IT) | 2010-01-20 | — | — | EP | disclosed |
| WO-2009102864-A1 | HEDGEHOG PATHWAY ANTAGONISTS AND METHODS OF USE | STANFORD UNIVERSITY (US) | 2009-08-20 | — | — | WO | disclosed |
| WO-2008142720-A2 | QUINAZOLIN-OXIME DERIVATIVES AS HSP90 INHIBITORS | DAC SRL (IT) | 2008-11-27 | — | — | WO | disclosed |
| WO-2008142720-A2 | QUINAZOLIN-OXIME DERIVATIVES AS HSP90 INHIBITORS | DAC SRL (IT) | 2008-11-27 | — | — | WO | disclosed |
| EP-1229019-A1 | PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE CYCLIC ENAMINONE DERIVATIVES | Takeda Chemical Industries, Ltd. (JP) | 2002-08-07 | — | — | EP | disclosed |
| US-6350749-B1 | SODIUM CHANNEL MODULATORS, ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS, ANGINA PECTORIS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-02-26 | — | — | US | disclosed |
| EP-1057812-A1 | AMINOGUANIDINE HYDRAZONE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND DRUGS THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-12-06 | — | — | EP | disclosed |
| US-4315006-A | Benzoxocin derivatives having anxiolytic and anti-convulsant activities | GLAXO GROUP LIMITED (GB) | 1982-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12209172-B2 | Curable compositions and methods of using the same | MAT2B, MAT1A, MTR | MAP1LC3B 204/4885TP53 2295/4885RECQL 1087/4885 |
| US-20260098012-A1 | TETRAHYDROACRIDINONE ANALOGUES FOR TREATMENT AND PREVENTION OF MALARIA | CD47, SLC11A2, G6PD | MAP1LC3B 288/4885TP53 4266/4885RECQL 2106/4885 |
| US-20230133261-A1 | CURABLE COMPOSITIONS AND METHODS OF USING THE SAME | MAT2B, MAT1A, MTR | MAP1LC3B 204/4885TP53 2295/4885RECQL 1087/4885 |
| US-20260102387-A1 | IMMUNOSUPPRESSIVE COMPOUNDS | CHP1, BRD3, IRF3 | MAP1LC3B 2145/4885TP53 1138/4885RECQL 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.